EGFR-216G/T polymorphism as a predictor of clinical outcomes in advanced non-small cell lung cancer patients treated with EGFR-TKIs: A meta-analysis.

Category Systematic review
JournalInternational Journal of Clinical and Experimental Medicine
Year 2016
This article has no abstract
Epistemonikos ID: 1e9b2489a057c8591a96f295c4bb57b013d5250e
First added on: Nov 22, 2016